Step into FREEDOM
Could you be a part of what's next for dcSSc?
The FREEDOM-3 clinical trial is researching the safety, tolerability, and effectiveness of a stem cell transplant with an investigational cell therapy in people with rapidly progressing diffuse cutaneous systemic sclerosis (dcSSc; also known as scleroderma) and who are at risk for organ failure.
Take a short survey to find out if you could qualify.
in the FREEDOM-3 trial.
The FREEDOM-3 clinical trial
The FREEDOM-3 clinical trial is studying an investigational cell therapy. It is an investigational stem and immune cell-based product that comes from a donor (who does not have dcSSc).
What is the investigational cell therapy?
FCR001 is an investigational stem and immune cell-based product that comes from your donor's blood.
About clinical trials
Clinical trials and the people who take part are what make medical advancements possible.
Resources
Read frequently asked questions and learn more about scleroderma.
Could you take part?
If you and your donor meet the eligibility criteria, you may qualify.
Take a short survey to find out.
in the FREEDOM-3 trial.
